AVITAR INC /DE/
8-K, 1997-02-04
HOME HEALTH CARE SERVICES
Previous: OWENS ILLINOIS INC /DE/, SC 13G, 1997-02-04
Next: NEUROCORP LTD, SB-2/A, 1997-02-04




<PAGE>

                    SECURITIES AND EXCHANGE COMMISSION

                          Washington, D.C.  20549


                                 FORM 8-K

                              CURRENT REPORT

  Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934


Date of Report (Date of earliest event reported) January 21, 1997
                                                -----------------


                           AVITAR, INC.
         -------------------------------------------------------
          (Exact name of registrant as specified in its charter)


        Delaware              0-20316              06-1174053
- ----------------------------------------------------------------
(State or other jurisdiction  (Commission        (IRS Employer
   of incorporation)          File Number)    Identification No.)



  65 Dan Road, Canton, MA                             02021
- -----------------------------------------------------------------
   (Address of principal executive offices)         (Zip Code)


Registrant's telephone number, including area code (617) 821-2440
                                                  ---------------







<PAGE>



Item 9.           Sales of Equity Securities Pursuant to Regulation S.


     On January 21, 1997, the Company sold 500,000 newly issued shares of Common
Stock for $103,000 in cash,  or a price of $0.206 per share  (approximately  40%
below the  then-current  market price as reported by NASD for the NASDAQ - Small
Cap market).

     The shares were offered and sold to Optimum Fund, a  corporation  organized
under the laws of the British West Indies (the  "Purchaser").  The Purchaser was
introduced to the Company by a distributor,  U.S. Milestone  Corporation,  a New
York corporation.

     In the  above-described  sale,  the Company  relied upon the exemption from
registration  under the  Securities Act of 1933, as amended ("the Act") provided
by  Regulation  S  promulgated  under the Act.  The sale was made  pursuant to a
certain offshore Securities Subscription Agreement, dated January 15, 1997, made
by and between the Company and the Purchaser  ("the  Agreement").  The Purchaser
represented and warranted,  among other things, that it is not a U.S. person (as
defined  in  Regulation  S) and that it  received  the  offer and  executed  the
Agreement outside the United States.  Further, the Purchaser agreed, among other
things,  that the purchased  shares will not be resold to U.S. persons or within
the United  States  during the period of 40 days  commencing  on the date of the
closing  of the  purchase  (January  21,  1997).  The  Company  represented  and
warranted,  among  other  things,  that the Company is in full  compliance  with
reporting  obligations  under Section  12(b),  12(g) or 15(d) of the  Securities
Exchange  Act of 1934,  as  amended,  and that the Company  reasonably  believed
Purchaser was outside the United States and not a U.S. person.































<PAGE>



                        SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                       AVITAR, INC.
                                       (Registrant)

Date: February 4, 1997            By: J.C. LEATHERMAN, JR.
                                     ------------------------
                                      J.C. LEATHERMAN, JR.,
                                      Chief Financial Officer



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission